We formulate inclusive cannabis
products for all walks of life.
Traditionally, consuming cannabis products via inhalation or smoking is considered The only way to reach a rapid cannabis therapeutic effect. This route of administration is not feasible for a wide range of patients due to age, medical conditions, or preference.
Elixie offers a range of standard medicinal cannabis products with diverse CBD and THC ratios designed to include every patient's need.
We develop products to meet the regulatory requirements of the different medical cannabis programs globally while considering and following the evolving framework in Canada and the US.
Soluboil is a line of products generated on the base of the Advanced Pro Nano Liposphere (PNL) technology.
Elixie Soluboil Capsules
Elixie's fast-acting soft-gel capsules offer a pivotal solution for those patients who require fast onset by utilizing the Advanced PNL technology to achieve a more immediate and amplified therapeutic effect. The technology also provides more consistent absorption and control both inter and interpatient.
With Elixie's capsule, patients can achieve fast onset in 15/20 minutes instead of current oral solutions that take around 45/90 minutes.
The capsule dosages were designed to enable a personal titration protocol based on consensus protocols and Elixie's cumulative clinical data to achieve the desired result with minimal adverse effects and maximum safety.
Elixie's solution allows the fastest onset via oral administration
and suits patients with swallowing issues or who need large doses.
The solution's administration is by dripping the dose into a glass of water. The solution is instantly dispersed into nanoparticles for optimal and immediate absorption.
With Elixie's capsule, patients can achieve fast onset in 5/10 minutes instead of current oral solutions that take around 45/90 minutes.
The solution suite enables a personal titration protocol based on consensus protocols and Elixie's cumulative clinical data to achieve the desired result with minimal adverse effects and maximum safety.
Elixie SL: Trans-Mucosal Delivery Device
Elixie's novel trans-mucosal drug delivery device enables a powerful combination of high efficiency and substantial patient compliance.
Drug release adjusted for optimal delivery, no spillage, and no swallowing avoid the first-pass effect problem by utilizing an intuitive thermometer-like administration that suits every age group and medical indication.
Adjustable for every liquid formulation, including pharmaceuticals, vaccines, allergens, cannabinoids, vitamins, and minerals.
Designed for medical device class 2 / 2a – FDA / CE